Skip to main
SIBN

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 7 analyst ratings
Strong Buy
Strong Buy 57%
Buy 43%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE Inc. demonstrated a robust financial performance in the second quarter of 2025, achieving a gross margin of 79.8%, reflecting an increase of approximately 80 basis points year-over-year. The company's revenue for the same period grew by around 23% year-over-year to $46.4 million, which is indicative of strong market demand and effective sales strategies, particularly as the number of engaged surgeons rose by approximately 25%. Furthermore, the revision of the 2025 revenue estimate to $196.5 million from $193.9 million highlights confidence in continued growth driven by enhanced sales productivity.

Bears say

The financial outlook for SI-BONE Inc reveals significant challenges, primarily due to sluggish growth in the global spine market, which has recently faced pricing pressures and procedural headwinds, resulting in growth rates in the low-single digits. Concerns are further compounded by potential reimbursement shifts from payors towards competitive products, which could lead to a decline in SI-BONE's market share within the sacroiliac joint fusion segment, negatively impacting revenue. Additionally, SI-BONE's EV/sales growth metric of 0.19x is substantially below the median of 0.34x for its growth peer group, indicating potential undervaluation relative to market expectations.

SI-BONE Inc (SIBN) has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 57% of analysts recommend a Strong Buy, 43% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Strong Buy based on their latest research and market trends.

According to 7 analysts, SI-BONE Inc (SIBN) has a Strong Buy consensus rating as of Jan 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $25.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $25.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.